News

InterCure Reports Strong Financial Performance in 2024

InterCure Reports Strong Financial Performance in 2024

InterCure Reports Impressive Results for the First Half of 2024

InterCure has announced remarkable revenue figures for the first half of 2024, totaling NIS 126 million. Additionally, the company achieved an adjusted EBITDA of NIS 21 million, which accounts for about 17% of its revenues. These financial results highlight the ongoing success of InterCure's operations and strategic initiatives.

Strong Growth Amidst Challenges

Both the first and second quarters of 2024 ended with positive EBITDAs and operational profits, marking InterCure's 16th and 17th consecutive quarters of profitability. The company's solid performance is particularly impressive given the challenges it has faced, including the effects of recent geopolitical events.

Effects of Recent Events

The revenue figures for this period were impacted by damages from a recent terrorist attack and the ongoing regional conflict. Nevertheless, InterCure is entitled to full compensation from local authorities for both direct and indirect damages sustained at its Southern Facility located in Kibbutz Nir Oz.

Compensation and Recovery Initiatives

So far, InterCure has received tens of millions of NIS in partial advance payments from the authorities, which have helped facilitate the restoration of its damaged facility. The company remains optimistic about its recovery efforts and is dedicated to restoring full operational capacity.

Strategic Partnerships and Future Growth

InterCure has expanded its strategic partnership with Cookies™ to include the German market, with plans to launch Cookies products by the fourth quarter of 2024. This strategic move is part of the company's broader objective to enhance its international presence and product offerings.

Growth Projections

Looking forward, InterCure anticipates achieving double-digit growth in the latter half of 2024 compared to the first half, driven by expected product launches in both the German and UK markets. This growth is supported by the company's commitment to expanding its premium product lines.

Financial Highlights

Alongside its revenue accomplishments, InterCure's operational profit for the first half of 2024 reached NIS 11 million. The company has cash reserves of NIS 21 million and maintains an unused credit line exceeding NIS 22 million. This financial strength positions InterCure well to support its expansion plans and recovery efforts.

CEO's Assurance to Shareholders

Alexander Rabinovitch, the CEO of InterCure, emphasized the company's focus on significant growth opportunities across all territories. The strategic measures taken to enhance cultivation and supply chains in Canada and Europe are crucial for future success. The entry into the German market, supported by Cookies, marks a significant advancement in providing high-quality products to consumers.

About InterCure

InterCure, which trades as Canndoc on NASDAQ and TASE, is recognized as Israel’s largest licensed cannabis producer. The company has established itself as a key player in the pharmaceutical cannabis market by leveraging its distribution network and partnerships while upholding high standards in product quality.

Frequently Asked Questions

What were InterCure's revenue figures for the first half of 2024?

InterCure reported revenues of NIS 126 million during the first half of 2024.

How did recent geopolitical events affect InterCure's operations?

The company experienced revenue impacts from damages related to a terrorist attack and ongoing conflict, affecting its Southern Facility's operations.

What is InterCure's plan for international expansion?

InterCure plans to launch Cookies™ products in Germany in Q4 of 2024 and anticipates double-digit growth in the second half of 2024.

How much cash does InterCure currently have on hand?

The company has reported cash reserves of NIS 21 million, with an unused credit line of over NIS 22 million available for further investments.

What differentiates InterCure in the cannabis market?

InterCure stands out due to its comprehensive seed-to-sale model, robust distribution network, and high-quality pharmaceutical-grade product offerings.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Redwood and SAP Partner on Secure File Transfer

Updated Category News Views 199

Redwood Advances SAP Interiors with New File Solution October 26, '26 is now a landmark for Redwood Software. They've just rolled out their SAP Managed File Transfer solution. Got the brainpower behind Redwood and SAP operating together here, and they're offering this to enterprises aimed at optimizing their file-based workflow. If you're scratching your head just hearing...

Continue Reading
Latham & Watkins Welcomes Privacy Sledgehammer Macko

Updated Category News Views 73

Privacy Enforcer Lands at Latham & Watkins With regulatory pressure turning up the heat, Latham & Watkins has roped in Michael Macko, a seasoned pro when it comes to privacy enforcement. To give you a peek into his credibility, Macko doesn't just have a foot in the door—he built the doorframe himself over at the California Privacy Protection Agency (CalPrivacy)....

Continue Reading
Navigating Headstone Choices Beyond Cemetery Norms

Updated Category News Views 62

Decoding Headstone Purchases: A Monumental Decision Headstones may not be on everyone's mind until they're suddenly front and center—a task during a time filled with emotions. Contrary to what many folks believe, the cemetery isn't the sole option for purchasing these memorials. The traditional route has always included cemeteries peddling everything you might need in...

Continue Reading
FFR Secures FFAI Robotics; Eyes Top Robotics Spot

Updated Category News Views 76

Shaking Up the Robotics Game: FFR's Bold Move The recent deal between FF EAI Robotics Ecosystem (FFR) and Faraday Future Intelligent Electric (FFAI) is one of those moments. You know, when a company decides to go big or go home. FFR completed the acquisition of FFAI's robotics arm, and they’ve been quick to swap stock with Smart Technology Holdings Ltd. Now, we’ve got...

Continue Reading
Touchmark's Q3 Bonanza: Income Leaps 39%, Stock Repurchase

Updated Category News Views 110

Ever seen a bank juggle financials like a street performer with flaming torches? That's Touchmark Bancshares for you this quarter. This Georgia-based community bank just released their third quarter 2026 results, and it seems they've not only mastered performance but also pranced around market risks effortlessly, much to the delight of investors. Breaking Down the Numbers...

Continue Reading
Netcapital's 28.62% Plunge: A Fraudulent Drama Unfolds

Updated Category News Views 82

Netcapital: The Plunge Heard 'Round the Market There it is, clear as day—Netcapital’s (NASDAQ: NCPL) stock plummeting 28.62% like a lead balloon. Shareholders had to watch in horror as pieces of their investments seemed to evaporate, all thanks to a swirl of alleged fraud. You can't just shrug off accusations that a company you've betted on has been cooking its books,...

Continue Reading
HDD vs SSD: EaseUS Report Shows Alarming Disk Health Trends

Updated Category News Views 51

Disks Under the Microscope: Key Insights from 2026 Report Well, here's a data nugget that'll make you rethink your storage options: EaseUS Software dropped a disk health bombshell with their 2026 report, putting HDDs in the hot seat. Turns out, HDDs are about as trustworthy as a flaky friend, clocking in at 20 times more caution or bad health ratings compared to their...

Continue Reading
Bladex Delivers Strong Q3 With $63M Net Profit

Updated Category News Views 0

Bladex Reports Impressive Q3 Profits Amid a sea of financial updates, Bladex's third-quarter numbers stand out like a lighthouse. They just flashed a $63.2 million net profit—up 15% from last year. That's the kind of growth that gets investors talking over their morning coffee. The magic behind these figures? Bladex managed to wrangle more revenue from net interest...

Continue Reading
Linkurious Named Category Leader in AML Monitoring

Updated Category News Views 141

Graph Intelligence: The Winning Edge You know, the financial crime scene ain't what it used to be. Gone are the days when a simple audit trail was enough to sniff out dirty money. Companies like Linkurious are pushing the envelope with graph-powered decision intelligence, and in 2026, they got the nod from Chartis Research as a Category Leader for AML Transaction...

Continue Reading
San Ysidro Urgent Care Addresses Care Desert in San Diego

Updated Category News Views 6

A Long Overdue Remedy in San Diego Healthcare access shouldn't be a roll of the dice based on where you live, but for too many folks in Southeastern San Diego, that’s been the sad reality. Today, though, there's a new twist in the tale. Blue Shield of California Promise Health Plan just dropped a hefty $1 million into an urgent care facility that’s more than bricks...

Continue Reading

Top 5 Most Recently Viewed Articles

MediCapture Unveils Innovative aiScope™ for Veterinary Applications

Updated Category News Views 114

MediCapture Introduces aiScope™ for Veterinary Training Revolutionizing Medical AI CHEROKEE, Texas — MediCapture Inc., recognized for its prowess in medical imaging technology, has announced the exciting launch of aiScope™. This innovative software operates Vision AI models in real-time, directly on selected MediCapture devices, providing tremendous opportunities in...

Continue Reading
Midland States Bancorp Set to Release Q4 2024 Outcomes Soon

Updated Category News Views 115

Midland States Bancorp Prepares for Fourth Quarter Financial Results Midland States Bancorp, Inc. has exciting news for its investors and stakeholders. The company is gearing up to announce its fourth quarter financial results for 2024. The announcement is set to take place after market close on a Thursday, providing valuable insights into the company’s performance....

Continue Reading
Newland & Newland, LLP Attorneys Honored as Elite Lawyers for 2025

Updated Category News Views 295

Newland & Newland, LLP Attorneys Honored as Elite Lawyers for 2025 Newland & Newland, LLP proudly announces recognition for six of its accomplished attorneys as Elite Lawyers for 2025. This prestigious title is exemplary of the high standards and trust established by the firm over nearly three decades of dedicated service. The attorneys who earned this accolade include...

Continue Reading
Investment Recovery Opportunities for Dow Inc. Shareholders

Updated Category News Views 92

Opportunity for Dow Inc. Investors to Recover Losses Levi & Korsinsky, LLP is reaching out to investors in Dow Inc. regarding a class action securities lawsuit designed specifically for those who experienced financial loss due to alleged misconduct by the company. Understanding the complexities of legal proceedings and the unfortunate events that can lead to such...

Continue Reading
Ericsson's Q2 2026 Results Show Strategic Gains Amid Challenges

Updated Category News Views 28

Disciplined Strategy Pays Dividends Ericsson's second-quarter results for 2026 tell quite the tale of a company that isn't just sitting back and letting the winds of financial uncertainty toss it around. Instead, it's more like they've grabbed the sails with some strategic gusto. All eyes are on those adjusted gross margins sitting pretty at 48.4%. You hold that line,...

Continue Reading